{"id":16949,"date":"2021-03-19T15:19:09","date_gmt":"2021-03-19T14:19:09","guid":{"rendered":"https:\/\/idibell.cat\/?p=16949"},"modified":"2021-03-19T15:21:02","modified_gmt":"2021-03-19T14:21:02","slug":"el-dr-xavier-matias-guiu-nou-president-de-la-societat-internacional-de-patolegs-ginecologics","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2021\/03\/el-dr-xavier-matias-guiu-nou-president-de-la-societat-internacional-de-patolegs-ginecologics\/","title":{"rendered":"El Dr. Xavier Matias-Guiu, nou president de la Societat Internacional de Pat\u00f2legs Ginecol\u00f2gics"},"content":{"rendered":"<p>La ISGYP (<a href=\"https:\/\/www.isgyp.org\/\">International Society of Gynecological Pathologists<\/a>) \u00e9s una societat cient\u00edfica, d\u2019abast mundial, de pat\u00f2legs amb un inter\u00e8s com\u00fa per la patologia del sistema reproductor femen\u00ed. La Societat es va fundar el 1976 per facilitar l&#8217;intercanvi de coneixements sobre malalties ginecol\u00f2giques i ser un f\u00f2rum de difusi\u00f3 de nova informaci\u00f3 en aquesta \u00e0rea.<\/p>\n<p>La pertinen\u00e7a est\u00e0 oberta a qualsevol pat\u00f2leg d\u2019acord amb les normatives o costums de cada pa\u00eds per als especialistes i que hagi contribu\u00eft al camp de la patologia ginecol\u00f2gica.<\/p>\n<p>La ISGYP s\u2019encarrega a nivell global de ser l\u2019interlocutor per a q\u00fcestions relatives a la patologia dels c\u00e0ncers ginecol\u00f2gics. Compta amb un programa de formaci\u00f3 en patologia ginecol\u00f2gica per a pat\u00f2legs de tot el m\u00f3n, amb l&#8217;organitzaci\u00f3 de reunions conjuntament amb la divisi\u00f3 americano-canadenca de la Acad\u00e8mia Internacional de Patologia (USCAP), la Societat Americana de Patologia Cl\u00ednica (ASCP), la Societat Internacional de C\u00e0ncer Ginecol\u00f2gic (IGCS) i la Societat Europea de Patologia (ESP), entre altres.<\/p>\n<p>Des de fa un any, la ISGYP ha promogut la formaci\u00f3 virtual mitjan\u00e7ant el programa ISGYP-life, amb quatre sessions mensuals, que ha tingut molta acceptaci\u00f3 a tots els \u00e0mbits geogr\u00e0fics. La ISGYP t\u00e9 com a publicaci\u00f3 pr\u00f2pia, l&#8217;International Journal of Gynecological Pathology.<\/p>\n<p>Entre els objectius que es planteja el Dr. Matias-Guiu, cap de grup a l\u2019<a href=\"https:\/\/idibell.cat\/recerca\/area-de-cancer\/programa-de-mecanismes-molleculars-i-terapia-experimental-en-oncologia-oncobell\/cancer-ginecologic\/\">IDIBELL<\/a> i cap del Servei d\u2019Anatomia Patol\u00f2gica de l\u2019Hospital Universitari de Bellvitge, durant els dos anys de presid\u00e8ncia hi ha el manteniment del programa de formaci\u00f3 virtual m\u00e9s enll\u00e0 de la situaci\u00f3 epidemiol\u00f2gica actual, incrementar la difusi\u00f3 de la ISGYP en tots els \u00e0mbits geogr\u00e0fics del m\u00f3n, especialment en els pa\u00efsos on est\u00e0 menys implantada, incrementar la relaci\u00f3 amb les associacions de malalts amb c\u00e0ncer ginecol\u00f2gic a nivell mundial, i promoure un estudi multic\u00e8ntric d\u2019abast mundial per proporcionar evid\u00e8ncia cient\u00edfica per optimitzar l&#8217;estadiatge del c\u00e0ncer d\u2019endometri.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><em>L\u2019Institut d&#8217;Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) \u00e9s un centre de recerca en biomedicina creat l\u2019any 2004. Est\u00e0 participat per l&#8217;Hospital Universitari de Bellvitge i l\u2019Hospital de Viladecans de l&#8217;Institut Catal\u00e0 de la Salut, l&#8217;Institut Catal\u00e0 d&#8217;Oncologia, la Universitat de Barcelona i l\u2019Ajuntament de l\u2019Hospitalet de Llobregat.<\/em><\/p>\n<p><em>L\u2019IDIBELL \u00e9s membre del Campus d&#8217;Excel\u00b7l\u00e8ncia Internacional de la Universitat de Barcelona HUBc i forma part de la instituci\u00f3 CERCA de la Generalitat de Catalunya. L&#8217;any 2009 es va convertir en un dels cinc primers centres d\u2019investigaci\u00f3 espanyols acreditats com a institut d\u2019investigaci\u00f3 sanit\u00e0ria per l\u2019Instituto de Salud Carlos III. A m\u00e9s, forma part del programa \u201cHR Excellence in Research\u201d de la Uni\u00f3 Europea i \u00e9s membre de EATRIS i REGIC. Des de l\u2019any 2018, l\u2019IDIBELL \u00e9s un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>El Dr Xavier Matias-Guiu, cap del grup de recerca en c\u00e0ncer ginecol\u00f2gic de l\u2019IDIBELL, \u00e9s des d&#8217;aquest cap de setmana el nou president de la Societat Internacional de Pat\u00f2legs Ginecol\u00f2gics (ISGYP).<\/p>\n","protected":false},"author":8,"featured_media":16950,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[332,365,447],"tags":[],"class_list":["post-16949","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cancer","category-cancer-ginecologic","category-p-de-mecanismes-molelculars-i-terapia-experimental-en-oncologia-oncobell"],"publishpress_future_action":{"enabled":false,"date":"2024-12-25 20:56:27","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/16949","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=16949"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/16949\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/16950"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=16949"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=16949"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=16949"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}